@article{mbs:/content/journal/acmi/10.1099/acmi.0.000212, author = "Chaudhry, Rama and Sreenath, K. and Vinayaraj, E. V. and Sahoo, Biswajeet and Vishnu Narayanan, M. R. and Kiran, K. V. P. Sai and Batra, Priyam and Rathor, Nisha and Singh, Sheetal and Mohan, Anant and Bhatnagar, Sushma", title = "Mycoplasma pneumoniae co-infection with SARS-CoV-2: A case report", journal= "Access Microbiology", year = "2021", volume = "3", number = "3", pages = "", doi = "https://doi.org/10.1099/acmi.0.000212", url = "https://www.microbiologyresearch.org/content/journal/acmi/10.1099/acmi.0.000212", publisher = "Microbiology Society", issn = "2516-8290", type = "Journal Article", keywords = "Mycoplasma pneumoniae", keywords = "co-infections", keywords = "therapy", keywords = "infection", keywords = "pneumonia", keywords = "COVID-19", eid = "000212", abstract = "We report co-infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and Mycoplasma pneumoniae in a patient with pneumonia in India. Atypical bacterial pathogens causing community-acquired pneumonia may share similar clinical presentations and radiographic features with SARS-CoV-2 making a thorough differential diagnosis essential. The co-infection of SARS-CoV-2 and M. pneumoniae is infrequently reported in the literature. Broader testing for common respiratory pathogens should be performed in severe COVID-19 cases to rule out other concurrent infections. Early identification of co-existing respiratory pathogens could provide pathogen-directed therapy, and can save patient lives during the ongoing COVID-19 outbreak.", }